{"id":"26110082685","number":"26110082685","name":"Darrell Bridges","source_name":"Darrell Bridges","organization":"","posted":"2026-10-20","received":"2026-10-20","body":"","attachments":["https://www.fcc.gov/ecfs/document/26110082685/1","https://www.fcc.gov/ecfs/document/26110082685/2","https://www.fcc.gov/ecfs/document/26110082685/3","https://www.fcc.gov/ecfs/document/26110082685/4","https://www.fcc.gov/ecfs/document/26110082685/5","https://www.fcc.gov/ecfs/document/26110082685/6","https://www.fcc.gov/ecfs/document/26110082685/7"],"attachment_names":{"https://www.fcc.gov/ecfs/document/26110082685/1":"FCC_13-84_Comment.pdf","https://www.fcc.gov/ecfs/document/26110082685/2":"Elsevier_Martin_Pall_2018.pdf","https://www.fcc.gov/ecfs/document/26110082685/3":"FMed-DryEye_2022.pdf","https://www.fcc.gov/ecfs/document/26110082685/4":"JCN_Neurological_2015.pdf","https://www.fcc.gov/ecfs/document/26110082685/5":"JMU_Antioxident_2017.pdf","https://www.fcc.gov/ecfs/document/26110082685/6":"USAF_1994.pdf","https://www.fcc.gov/ecfs/document/26110082685/7":"NMRI_RF_Biblio_1971.pdf"},"attachment_inventory":true,"withheld":false,"source":"https://www.fcc.gov/ecfs/filing/26110082685","filing_type":"COMMENT","proceedings":"ET 13-84","capture_reviewed":false,"captured_at":"2026-10-23T00:22:59.797Z","supplied_classification":null,"tags":["attachments-only"],"source_hash":"b2825e26bf7e9dd7d69042a2a2b99082efbbaaa782d3de8411664c7057af4e68","slug":"attachments-only-filing-26110082685","classification":{"id":"26110082685","body_sha256":"e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855","status":"text_matched","primary_topic":"attachments-only","topics":[{"id":"attachments-only","evidence":""}],"summary":"","method":"Local topic rules v1; exact supporting passages; not an AI or medical review","scope":"Captured filing text only. Attachment contents not examined."},"forum_topics":["attachments-only"],"primary_topic":"attachments-only","forum_title":"Attachment-only filing · Darrell Bridges"}